CRANBURY, N.J.--(BUSINESS WIRE)--Pharmacy Times Continuing Education™ (PTCE), a leader in continuing education for retail, health-system, managed care, oncology and specialty pharmacists, will host the live virtual symposium, “Novel Therapies for Treating Neuromyelitis Optica Spectrum Disorder: The Role of the Specialty and Infusion Pharmacist,” on Thursday, Nov. 14, from 7-8 p.m. EST. The symposium will examine the rare disease neuromyelitis optica spectrum disorder (NMOSD) and the associated pathophysiology, epidemiology and clinical presentation.
The symposium will feature Erica Marini, Pharm.D., MS, BCPS, clinical pharmacist in the department of neurology at the University of Utah Health.
“We are excited to have Erica Marini presenting this live virtual symposium,” said Jim Palatine, RPh, MBA, president of PTCE. “NMOSD is a rare and devastating disease, and it is our goal to prepare specialty and infusion pharmacists to be able to differentiate between NMOSD and multiple sclerosis.”
Throughout the activity, videos will demonstrate appropriate medication preparation techniques and highlight critical educational points for specialty and infusion pharmacists. This symposium will also identify practices for preparing, dispensing and monitoring new and emerging treatment therapies for NMOSD as well as counseling patients.
Accredited by the Accreditation Council for Pharmacy Education, this activity is approved for 1.0 contact hour and is supported by an educational grant from Alexion Pharmaceuticals, Inc.
To learn more and to register, click here.
About Pharmacy Times Continuing Education™
Pharmacy Times Continuing Education™ (PTCE) is a leader in continuing education for retail, health-system, managed care and specialty pharmacists. PTCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE). PTCE’s print, online and live CPE activities are designed to improve the knowledge, competence and skills of pharmacists to better prepare them to provide the highest quality of pharmacy care to the patients they serve and the physicians they assist as part of a multidisciplinary treatment and management team. PTCE is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in the U.S. dedicated to delivering trusted health care news across multiple channels.
